The combined Orthofix will have orthopedic sales that approach $700 million for 2022, making it the ninth largest player in the industry.
Mid-tier companies Orthofix and SeaSpine merged in early January 2023 to become the ninth-largest company in orthopedics.
The acquisition includes the TAPESTRY biointegrative implant for tendon healing and TAPESTRY RC for rotator cuff repair.
Mid-tier companies Orthofix and SeaSpine merged in early January 2023 to become the ninth-largest company in orthopedics.
The acquisition expands Companion Spine’s portfolio with Backbone’s LISA lumbar implant for stiffness augmentation.
OrthoPediatrics’ first direct international organization represents an expanding commitment to support pediatric orthopedics in international markets.
The combined Orthofix will have orthopedic sales that approach $700 million for 2022, making it the ninth largest player in the industry.
After peaking in 2020, orthopedic M&A volume declined more than 40% in 2021 and dropped another 12% in 2022.
The acquisition includes the TAPESTRY biointegrative implant for tendon healing and TAPESTRY RC for rotator cuff repair.
The combined organization creates the eighth-largest spine company, with a portfolio spanning trauma, orthobiologics and bone growth therapies.
The companies will co-develop spine surgery applications and co-market the eCential Robotics open robotic surgery platform.
More market entrants and sustained economic pressures have changed the game for hospitals acquiring capital equipment like orthopedic robots.
The companies will develop a connected care solution to enhance the surgical planning experience using THINK’s robotic technologies for joint replacement.
Lazurite’s ArthroFree wireless surgical camera system is FDA-cleared for arthroscopy and general endoscopy applications.
The partnership broadens the supply of Enovis’ joint replacement devices for shoulder, hip, knee and extremities.
The agreement allows Implanet to exclusively distribute the latest generation SMTP ultrasonic surgical scalpel in France.
This partnership aims to develop a new European hybrid fixation system, incorporating the latest developments in the field of spine surgery.
The corporate restructuring plan is intended to help drive growth in the most valuable and profitable parts of the company’s business.
Login
Register for a free account
As a guest member you get access to more articles and webinars every month.